Suchergebnisse - "Turkina, Anna"

PubPharm (63)

1

Chronic myeloid leukemia diagnosed in pregnancy : management and outcome of 87 patients reported to the European LeukemiaNet international registry

enthalten in: Leukemia | 2024

von Chelysheva, E. | Apperley, J. | Turkina, A. | +16

2

Morphological Evaluation and Immunohistochemical Analysis of the Reparative Potential of the Buccal Fat Pad

enthalten in: Medicina (Kaunas, Lithuania) | 2024

von Zhidkov, R. | Panin, A. | Drobyshev, A. | +12

3

Oral Galvanism Side Effects : Comparing Alloy Ions and Galvanic Current Effects on the Mucosa-like Model

enthalten in: Journal of functional biomaterials | 2023

von Chepelova, N. | Antoshin, A. | Voloshin, S. | +7

4

Clinical Outcomes in Patients With COVID-19 and Hematologic Disease

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Aleshina, O. | Zakurdaeva, K. | Vasileva, A. | +32

5

The Impact of Commercially Available Dry Mouth Products on the Corrosion Resistance of Common Dental Alloys

enthalten in: Materials (Basel, Switzerland) | 2023

von Turkina, A. | Makeeva, I. | Dubinin, O. | +7

6

Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors : longer-term follow-up of ASCEMBL

enthalten in: Leukemia | 2023

von Hochhaus, A. | Réa, D. | Boquimpani, C. | +23

7

Minimization of Adverse Effects Associated with Dental Alloys

enthalten in: Materials (Basel, Switzerland) | 2022

von Arakelyan, M. | Spagnuolo, G. | Iaculli, F. | +4

8

The Electrical Activity of the Orbicularis Oris Muscle in Children with Down Syndrome-A Preliminary Study

enthalten in: Journal of clinical medicine | 2021

von Szyszka-Sommerfeld, L. | Sycińska-Dziarnowska, M. | Woźniak, K. | +4

9

Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia : a randomized, open-label phase 2 clinical trial

enthalten in: Blood | 2021

von Cortes, J. | Apperley, J. | Lomaia, E. | +22

CommentIn: Blood. 2021 Nov 25;138(21):2011-2012. - PMID 34821935

10

A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs

enthalten in: Blood | 2021

von Réa, D. | Mauro, M. | Boquimpani, C. | +23

CommentIn: Blood. 2021 Nov 25;138(21):2009-2010. - PMID 34821938

1
2
3
4
5
6
7
Nächster »
[7]